[1]
Al-Samkari H, Berliner N. Hemophagocytic Lymphohistiocytosis. Annual review of pathology. 2018 Jan 24:13():27-49. doi: 10.1146/annurev-pathol-020117-043625. Epub 2017 Sep 13
[PubMed PMID: 28934563]
[2]
Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management. Pediatrics international : official journal of the Japan Pediatric Society. 2016 Sep:58(9):817-25. doi: 10.1111/ped.13064. Epub
[PubMed PMID: 27289085]
[3]
Janka GE. Familial hemophagocytic lymphohistiocytosis. European journal of pediatrics. 1983 Jun-Jul:140(3):221-30
[PubMed PMID: 6354720]
[4]
Schram AM, Comstock P, Campo M, Gorovets D, Mullally A, Bodio K, Arnason J, Berliner N. Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. British journal of haematology. 2016 Feb:172(3):412-9. doi: 10.1111/bjh.13837. Epub 2015 Nov 5
[PubMed PMID: 26537747]
[5]
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM, Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016 Jun 2:127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10
[PubMed PMID: 26966089]
[6]
Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematology. American Society of Hematology. Education Program. 2015:2015():177-82. doi: 10.1182/asheducation-2015.1.177. Epub
[PubMed PMID: 26637718]
[7]
Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet (London, England). 2014 Apr 26:383(9927):1503-1516. doi: 10.1016/S0140-6736(13)61048-X. Epub 2013 Nov 27
[PubMed PMID: 24290661]
[8]
Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. The Journal of pediatrics. 1985 Apr:106(4):561-6
[PubMed PMID: 3981309]
[9]
Meeths M, Horne A, Sabel M, Bryceson YT, Henter JI. Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden. Pediatric blood & cancer. 2015 Feb:62(2):346-352. doi: 10.1002/pbc.25308. Epub 2014 Nov 8
[PubMed PMID: 25382070]
[10]
Niece JA, Rogers ZR, Ahmad N, Langevin AM, McClain KL. Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race. Pediatric blood & cancer. 2010 Mar:54(3):424-8. doi: 10.1002/pbc.22359. Epub
[PubMed PMID: 19953651]
[11]
Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clinic proceedings. 2014 Apr:89(4):484-92. doi: 10.1016/j.mayocp.2013.12.012. Epub 2014 Feb 26
[PubMed PMID: 24581757]
[12]
Henter JI, Elinder G, Söder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta paediatrica Scandinavica. 1991 Apr:80(4):428-35
[PubMed PMID: 2058392]
[13]
Dufourcq-Lagelouse R, Jabado N, Le Deist F, Stéphan JL, Souillet G, Bruin M, Vilmer E, Schneider M, Janka G, Fischer A, de Saint Basile G. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. American journal of human genetics. 1999 Jan:64(1):172-9
[PubMed PMID: 9915956]
[14]
Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, Meller J, Villanueva J, Risma KA, Wei Q, Klein PS, Filipovich AH. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011 Nov 24:118(22):5794-8. doi: 10.1182/blood-2011-07-370148. Epub 2011 Aug 31
[PubMed PMID: 21881043]
[15]
Maschalidi S, Sepulveda FE, Garrigue A, Fischer A, de Saint Basile G. Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. Blood. 2016 Jul 7:128(1):60-71. doi: 10.1182/blood-2016-02-700013. Epub 2016 May 24
[PubMed PMID: 27222478]
[16]
Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan MB, La Rosée P, Kantarjian HM. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017 Sep 1:123(17):3229-3240. doi: 10.1002/cncr.30826. Epub 2017 Jun 16
[PubMed PMID: 28621800]
[17]
Smith MC, Cohen DN, Greig B, Yenamandra A, Vnencak-Jones C, Thompson MA, Kim AS. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder. International journal of clinical and experimental pathology. 2014:7(9):5738-49
[PubMed PMID: 25337215]
[18]
Henter JI, Samuelsson-Horne A, Aricò M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G, Histocyte Society. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002 Oct 1:100(7):2367-73
[PubMed PMID: 12239144]
[19]
Bergsten E, Horne A, Aricó M, Astigarraga I, Egeler RM, Filipovich AH, Ishii E, Janka G, Ladisch S, Lehmberg K, McClain KL, Minkov M, Montgomery S, Nanduri V, Rosso D, Henter JI. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017 Dec 21:130(25):2728-2738. doi: 10.1182/blood-2017-06-788349. Epub 2017 Sep 21
[PubMed PMID: 28935695]
[20]
Aricò M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996 Feb:10(2):197-203
[PubMed PMID: 8637226]
[21]
Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric blood & cancer. 2007 Feb:48(2):124-31
[PubMed PMID: 16937360]
[22]
Marsh RA, Vaughn G, Kim MO, Li D, Jodele S, Joshi S, Mehta PA, Davies SM, Jordan MB, Bleesing JJ, Filipovich AH. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood. 2010 Dec 23:116(26):5824-31. doi: 10.1182/blood-2010-04-282392. Epub 2010 Sep 20
[PubMed PMID: 20855862]